PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aqueous extract and t-DCTN significantly reduced blood glucose and triglyceride levels in diabetic rats [PMID:21140094, 11903418]. Bark infusion reduced plasma triglyceride levels by 40% in hyperlipidemic mice [PMID:15381962].
t-DCTN and essential oils showed significant antiulcerogenic effects in rat models induced by ethanol, hypothermic restraint stress, and pylorus ligature [PMID:9525103, 10344636]. A polysaccharide fraction from leaves also promoted gastroprotection in ethanol-induced models [PMID:27864055].
Fractions of a leaf decoction and the bark's essential oil exhibited anti-inflammatory and antinociceptive properties in rodent models [PMID:28826140, 10678502].
7-hydroxycalamenene-rich essential oils showed activity against MRSA, Mycobacterium tuberculosis, and Candida species [PMID:23325101, 27019560]. Extracts and terpenes showed activity against Leishmania amazonensis and Leishmania chagasi [PMID:24088644, 26547537, 16099722].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37587801 (2024) — Croton cajucara: Patents and Nanotechnological Advances. · Recent patents on nanotechnology
- 2.PMID: 21140094 (2010) — Hepatics alterations and genotoxic effects of Croton cajucara Benth (SACACA) in diabetic rats. · Arquivos de gastroenterologia
- 3.PMID: 28826140 (2017) — Phytochemical analysis and anti-inflammatory evaluation of compounds from an aqueous extract of Croton cajucara Benth. · Journal of pharmaceutical and biomedical analysis
- 4.PMID: 37886132 (2023) — Red sacaca essential oil-loaded nanostructured lipid carriers optimized by factorial design: cytotoxicity and cellular reactive oxygen species levels. · Frontiers in pharmacology
- 5.PMID: 18372957 (2008)